Overexpression of the type-1 insulin-like growth factor receptor increases ligand-dependent proliferation and differentiation in bovine skeletal myogenic cultures

Journal of Cellular Physiology

Volumn 168, Issue 1, 1996, Pages 34-41

  Quinn, Lebris S ^a   Haugk, Kathleen L ^b  

^a GRECC 505/151   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; ARTICLE; CATTLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; EXPRESSION VECTOR; MUSCLE DEVELOPMENT; MUSCLE GROWTH; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DENSITY; SKELETAL MUSCLE;

ANIMALS; CATTLE; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; INSULIN-LIKE GROWTH FACTOR I; LIGANDS; MUSCLE, SKELETAL; RECEPTOR, IGF TYPE 1; RECOMBINANT PROTEINS;

EID: 0030016957     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199607)168:1<34::AID-JCP5>3.0.CO;2-9     Document Type: Article

References (44)

1. Allen, R.E., and Boxhorn, L.K. (1987) Inhibition of skeletal muscle satellite cell differentiation by transforming growth factor-beta. J. Cell. Physiol., 133:567-572.
2. Allen, R.E., Merkel, R.A., and Young, R.B. (1979) Cellular aspects of muscle growth: Myogenic cell proliferation. J. Anim. Sci., 49:115-126.
3. Bader, D., Masaki, T., and Fischman, D.A. (1982) Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro. J. Cell Biol., 95:763-770.
4. Beguinot, F., Kahn, C.R., Moses, A.C., and Smith, R.J. (1985) Distinct biologically active receptors for insulin, insulin-like growth factor I, and insulin-like growth factor II in cultured skeletal muscle cells. J. Biol. Chem., 260:15892-15898.
5. Chen, G., Birnbaum, R S., Yablonka-Reuveni, Z., and Quinn, L.S. (1994) Separation of mouse crushed muscle extract into distinct mitogenic activities by heparin affinity chromatography. J. Cell. Physiol., 160:563-572.
6. Ewton, D.Z., Falen, S.L., and Florini, J.R. (1987) The type II IGF receptor has low affinity for IGF-I analogs: Pleiotropic actions of IGFs on myoblasts are apparently mediated by the type I receptor. Endocrinology, 120:115-123.
7. Ewton, D.Z., Roof, S.L., Magri, K.A., McWade, F.J., and Florini, J.R. (1994) IGF-II is more active than IGF-I in stimulating L6A1 myogenesis: Greater mitogenic actions of IGF-I delay differentiation. J. Cell. Physiol., 161:277-284.
8. Flier, J.S., Usher, P., and Moses, A.C. (1986) Monoclonal antibody to the type I insulin-like growth factor (IGF-I) receptor blocks IGF-I receptor-mediated DNA synthesis: Clarification of the mitogenic mechanisms of IGF-I and insulin in human skin fibroblasts. Proc. Natl. Acad. Sci. U.S.A., 83:664-668.
9. Florini, J.R., Ewton, D.Z., Falen, S.L., and Van Wyk, J.J. (1986a) Biphasic concentration dependency of stimulation of myoblast differentiation by somatomedins. Am. J. Physiol., 250:C771-C778.
10. Florini, J.R., Roberts, A.B., Ewton, D.Z., Falen, S.B , Flanders, K.C., and Sporn, M.B. (1986b) Transforming growth factor-β. A very potent inhibitor of myoblast differentiation, identical to the differentiation inhibitor secreted by buffalo rat liver cells. J. Biol. Chem., 261:16509-16513.
11. Greene, E.A., and Allen, R.E. (1991) Growth factor regulation of bovine satellite cell growth in vitro. J. Anim. Sci., 69:146-152.
12. Gussom, E., Pavlath, G.K., Lanctot, A.M., Sharma, K.R., Miller, R.G., Steinman, L., and Blau, H.M. (1992) Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation. Nature, 356:435-438.
13. Kaleko, M., Rutter, W.J., and Miller, A.D. (1990) Overexpression of the human insulinlike growth factor I receptor promotes ligand-dependent neoplastic transformation. Mol. Cell. Biol., 10:464-473.
14. Karpati, G., Pouliot, Y., Zubrzycka-Gaarn, E., Carpenter, S., Ray, P.N., Worton, R.G., and Holland, P. (1989) Dystrophin is expressed in mdx skeletal muscle fibres after normal myoblast implantation. Am. J. Pathol., 135:27-32.
15. Kiess, W., Haskell, J.F., Lee, L., Greenstein, L.A., Miller, B.E., Aaron, A.L., Rechler, M., and Nissley, S.P. (1987) An antibody that blocks insulin-like growth factor (IGF) binding to the type II receptor is neither an agonist nor an inhibitor of IGF-stimulated biologic responses in L6 myoblasts. J. Biol. Chem., 262:12745-12751.
16. Kull, F.C., Jacobs, S., Su, Y.F., Svoboda, M.V., Van Wyk, J.J., and Cuatrecasas, P. (1983) Monoclonal antibodies to receptors for insulin and somatomedin-C. J. Biol. Chem., 258.6561-6565.
17. Magri, K.A., Ewton, D.Z., and Florini, J.R. (1991) The role of the IGFs in myogenic differentiation. In: Molecular Biology and Physiology of Insulin and Insulin-Like Growth Factors. M.K. Raizada and D. LeRoith, eds. Plenum Press, New York, pp. 57-76.
18. Mendell, J.R., Kissel, J.T., Amato, A.A., King, W., Signore, L., Prior, T.W., Sahenk, Z., Benson, S., McAndrew, P.E., Rice, R., Nagaraja, H., Stephens, R., Lantry, L., Morris, G.E., and Burghes, A.H.M. (1995) Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N. Engl. J. Med., 333:832-838.
19. Miller, A.D., and Buttimore, C. (1986) Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol., 6:2895-2902.
20. Miller, A.D., and Rosman, G.J. (1989) Improved retroviral vectors for gene transfer and expression. Biotechniques, 7:980-990.
21. Morgan, J.E., Moore, S.E., Walsh, F.S., and Partridge, T.A. (1992) Formation of skeletal muscle in vivo from the mouse C2 cell line. J Cell Sci., 102:779-787.
22. Morgan, J.E., Beauchamp, J.R., Pagel, C.N., Peckham, M., Ataliotis, P., Jat, P.S., Noble, M.D., Farmer, K, and Partridge, T.A. (1994) Myogenic cell lines derived from transgenic mice carrying a thermolabile T antigen: A model system for the derivation of tissue-specific and mutation-specific cell lines. Dev. Biol., 162:486-498.
23. Olson, E.N., Sternberg, E., Hu, J.S., Spizz, G., and Wilcox, C. (1986) Regulation of myogenic differentiation by transforming growth factor. J. Cell Biol., 103:1799-1805.
24. Partridge, T.A., Morgan, J.E., Coulton, G.R., Hoffman, E.P., and Kunkel, L.M. (1989) Conversion of mdx myofibers from dystrophin-negative to positive by injection of normal myoblasts. Nature, 337:176-179.
25. Partridge, T.A., Morgan, J.E., Pagel, C.N., Coulton, G.R., Skynner, M.F., Coleman, M., and Watt, D.J. (1992) Myoblast transplantation. In: Duchenne Muscular Dystrophy: Animal Models and Genetic Manipulations. B.A. Kakulas, J. McC Howell, and A.D. Roses, eds. Raven Press, New York, pp. 175-187.
26. Pilch, P.F., and Czech, M.P. (1979) Interaction of crosslinking agents with the insulin effector system of isolated fat cells. J. Biol. Chem., 254:3375-3381.
27. Quinn, L.S., and Roh, J.S. (1993) Overexpression of the human type-1 insulin-like growth factor receptor in rat L6 myoblasts induces ligand-dependent cell proliferation and inhibition of differentiation. Exp. Cell Res., 203:504-508.
28. Quinn, L.S , Holtzer, H., and Nameroff, M. (1985) Generation of chick skeletal muscle cells in groups of 16 from stem cells. Nature, 313:692-694.
29. Quinn, L.S., Norwood, T.H., and Nameroff, M. (1988) Myogenic stem cell commitment probability remains constant as a function of organismal and mitotic age. J. Cell. Physiol., 134:324-336.
30. Quinn, L.S., Ong, L.D., and Roeder, R.A. (1990) Paracrine control of myoblast proliferation and differentiation by fibroblasts. Dev. Biol., 70:8-19.
31. Quinn, L.S., Ehsan, M., Steinmetz, B., and Kaleko, M. (1993) Ligand-dependent inhibition of myoblast differentiation by overexpression of the type-1 insulin-like growth factor receptor. J. Cell. Physiol., 156:453-461.
32. Quinn, L.S., Steinmetz, B., Maas, A., Ong, L., and Kaleko, M. (1994) Type-1 insulin-like growth factor receptor overexpression produces dual effects on myoblast proliferation and differentiation. J. Cell. Physiol., 159:387-398.
33. Rando, T.A., and Blau, H.M. (1994) Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J. Cell Biol., 125:1275-1287.
34. Rosenblatt, J.D., and Parry, D.J. (1993) Adaptation of rat extensor digitorum longus muscle to gamma irradiation and overload. Pflugers Arch., 423:255-264.
35. Steele-Perkins, G., Turner, J., Edman, J.C., Harri, H., Pierce, S.B., Stover, C., Rutter, W J., and Roth, R.A. (1988) Expression and characterization of a functional human insulin-like growth factor receptor. J. Biol. Chem., 263:11486-11492.
36. Stockdale, F.E. (1992) Myogenic cell lineages. Dev. Biol., 154:284-298.
37. Stuart, C A., Brosnan, P.G., and Furlanetto, R.W. (1984) The somatomedin-C receptor of human placenta. Metabolism, 33:90-96.
38. Tollefsen, S.E., Sadow, J.L., and Rotwein, P. (1989a) Coordinate expression of insulin-like growth factor II and its receptor during muscle differentiation. Proc. Natl. Acad. Sci. U.S.A., 86:1543-1547.
39. Tollefsen, E.E., Lajara, R., McCusker, R.H., Clemmons, D.R., and Rotwein, P. (1989b) Insulin-like growth factors in muscle develop-ment. Expression of IGF-1, the IGF receptor, and an IGF binding protein during myoblast differentiation J. Biol. Chem., 264:13810-13817.
40. Ullrich, A., Gray, A., Tam, A.W., Yang-Geng, T., Tsubokawa, M., Collins, C., Henzel, W., LeBon, T., Kathuria, S., Chen, E., Jacobs, S., Francke, U., Ramachandran, J., and Fujita Yamaguchi, Y. (1986) Insulin-like growth factor I receptor primary structure: Comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J., 5:2503-2512.
41. Wernig, A., Irintchev, A., Hartling, A., Stephan, G., Zimmermann, K., and Starzinski-Powitz, A. (1991) Formation of new muscle fibers and tumours after injection of cultured myogenic cells. J. Neurocytol., 20:982-997.
42. White, T.P., and Esser, K.A. (1989) Satellite cell and growth factor involvement in skeletal muscle growth. Med. Sci. Sports Exerc., 21.S158-S163.
43. Whitson, P.A., Sutart, C.A., Huls, M.H., Sams, C.F., and Cintron, N.M. (1989) Dexamethasone effects on creatine kinase activity and insulin-like growth factor receptors in cultured muscle cells. J. Cell. Physiol., 140.8-17.
44. Yang, J., Seelig, M., Rayner, S., and Bredesen, D.E. (1992) Increasing the proliferative capacity of muscular dystrophy myoblasts. Muscle Nerve, 15:941-948.